申请人:Procter & Gamble Company
公开号:US06117867A1
公开(公告)日:2000-09-12
Substituted 6-R-1,3,4-thiadiazin-2-amines of the following general formula: ##STR1## wherein Ar is phenyl or phenyl optionally substituted with one or more chloro, bromo atoms, C.sub.1 -C.sub.4 alkoxy or C.sub.1 -C.sub.4 alkyl groups; R.sup.1 and R.sup.2 are each independently hydrogen atom or C.sub.1 -C.sub.4 alkyl moiety; and R.sup.3 and R.sup.4 are independently selected from C.sub.1 -C.sub.4 alkyl groups and pharmaceutically acceptable salts thereof, the use of them as anaesthetics, cardiovascular and hypometabolic agents and pharmaceutical compositions containing them.
以下是通式为##STR1##的6-R-1,3,4-噻二嗪-2-胺类化合物的替代物:其中Ar为苯基或苯基,可选地取代一个或多个氯、溴原子、C.sub.1-C.sub.4烷氧基或C.sub.1-C.sub.4烷基基团;R.sup.1和R.sup.2各自独立地为氢原子或C.sub.1-C.sub.4烷基基团;R.sup.3和R.sup.4各自独立地选自C.sub.1-C.sub.4烷基基团及其药学上可接受的盐,其用作麻醉剂、心血管和低代谢药物以及含有它们的制剂。